General Generative AI-driven drug Rentosertib enters Phase III trial for idiopathic pulmonary fibrosisBy Healthcare Propulsion StaffSeptember 10, 20260 Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, today announced that it has dosed the first patient with…
